Ultralife Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	191.16	164.46	158.64	131.84	98.27
Revenue Growth (YoY)	16.24%	3.66%	20.33%	34.16%	-8.77%
Cost of Revenue	145.14	122.14	119.44	102.44	73.63
Gross Profit	46.02	42.31	39.2	29.4	24.64
Selling, General & Admin	29.34	24.08	22.19	22.19	17.78
Research & Development	10.4	8.27	7.53	7.08	6.83
Other Operating Expenses	12.18	-	-	-	-
Total Operating Expenses	51.92	32.35	29.73	29.27	24.61
Operating Income	-5.9	9.97	9.48	0.13	0.04
Total Non-Operating Income (Expense)	-2.5	3.33	0.72	1.15	0.37
Pretax Income	-8.4	8.3	9.12	-0.45	-0.15
Provision for Income Taxes	-2.45	1.89	1.95	-0.33	0.08
Net Income	-5.9	6.31	7.2	-0.12	-0.23
Minority Interest in Earnings	-0.05	0.1	-0.03	-0	0
Net Income to Common	-5.9	6.31	7.2	-0.12	-0.23
Net Income Growth	-	-12.30%	-	-	-
Shares Outstanding (Basic)	17	17	16	16	16
Shares Outstanding (Diluted)	17	17	16	16	16
Shares Change (YoY)	-0.75%	3.33%	0.63%	0.55%	-0.37%
EPS (Basic)	-0.35	0.38	0.44	-0.01	-0.01
EPS (Diluted)	-0.35	0.38	0.44	-0.01	-0.01
EPS Growth	-	-13.64%	-	-	-
Free Cash Flow	0	14.7	-0.62	-2.94	1.51
Free Cash Flow Growth	-	-	-	-	-91.88%
Free Cash Flow Per Share	-	0.88	-0.04	-0.18	0.09
Gross Margin	24.07%	25.73%	24.71%	22.30%	25.08%
Operating Margin	-3.09%	6.06%	5.97%	0.10%	0.04%
Profit Margin	-3.11%	3.90%	4.52%	-0.09%	-0.23%
FCF Margin	0.00%	8.94%	-0.39%	-2.23%	1.54%
EBITDA	-5.9	14.21	13.45	4.62	3.68
EBITDA Margin	-3.09%	8.64%	8.48%	3.51%	3.74%
EBIT	-5.9	9.97	9.48	0.13	0.04
EBIT Margin	-3.09%	6.06%	5.97%	0.10%	0.04%
Effective Tax Rate	29.14%	22.79%	21.40%	73.09%	-52.32%

Updated Mar 10, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q